Your browser doesn't support javascript.
loading
Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus.
Sathe, Nikhil; Shaikh, Sameer; Bhavsar, Mahesh; Parte, Leena; Gadiparthi, Anjaneyulu; Kad, Satish; Sensarma, Sayandev; Nalband, Hassan; Sangapillai, R; Sivashanmuganathan, S; Pusalkar, Rakhi; Anandan, Sathyavathy; Masand, Girish; Pratapreddy, K; Harinarayana Rao, S; Gokhale, Abhiram; Vidyadhar Reddy, G E C; Karanam, Gopala; Phatarphekar, Abhishek; Rao, Praveen; Ramana, Venkata; Ramnath, R L.
Affiliation
  • Sathe N; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Shaikh S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Bhavsar M; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Parte L; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Gadiparthi A; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Kad S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Sensarma S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Nalband H; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Sangapillai R; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Sivashanmuganathan S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Pusalkar R; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Anandan S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Masand G; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Pratapreddy K; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Harinarayana Rao S; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Gokhale A; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Vidyadhar Reddy GEC; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Karanam G; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Phatarphekar A; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Rao P; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Ramana V; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India.
  • Ramnath RL; Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mumbai 400701, India. Electronic address: ramnath.l@relbio.com.
Vaccine ; 42(5): 1051-1064, 2024 Feb 15.
Article in En | MEDLINE | ID: mdl-37816655

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Subunit / COVID-19 Limits: Animals / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Subunit / COVID-19 Limits: Animals / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: India